Cargando…

Erratum: Superparamagnetic Iron Oxide-C595: Potential MR Imaging Contrast Agents for Ovarian Cancer Detection

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416867/ https://www.ncbi.nlm.nih.gov/pubmed/32831497 http://dx.doi.org/10.4103/0971-6203.290236

Ejemplares similares

Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2013)

Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma
por: Toma, A, et al.
Publicado: (2005)

Diffusion-Weighted MR Imaging before and after Contrast Enhancement with Superparamagnetic Iron Oxide for Assessment of Hepatic Metastasis
por: Kim, Hana, et al.
Publicado: (2012)

Comparison of Two Ultrasmall Superparamagnetic Iron Oxides on Cytotoxicity and MR Imaging of Tumors
por: Li, Mulan, et al.
Publicado: (2012)

New MRI contrast agents based on silicon nanotubes loaded with superparamagnetic iron oxide nanoparticles
por: Gonzalez-Rodriguez, Roberto, et al.
Publicado: (2018)

Polymer-coated superparamagnetic iron oxide nanoparticles as T(2) contrast agent for MRI and their uptake in liver
por: Ali, Lamiaa MA, et al.
Publicado: (2017)

Detection of MUC1-Expressing Ovarian Cancer by C595 Monoclonal Antibody-Conjugated SPIONs Using MR Imaging
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2013)

T(1)–T(2) Molecular Magnetic Resonance Imaging of Renal Carcinoma Cells Based on Nano-Contrast Agents [Erratum]
Publicado: (2023)

Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization
por: Wagner, Susanne, et al.
Publicado: (2013)

Mn(ii) chelate-coated superparamagnetic iron oxide nanocrystals as high-efficiency magnetic resonance imaging contrast agents
por: Wu, Changqiang, et al.
Publicado: (2020)

Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents
por: Di Marco, Mariagrazia, et al.
Publicado: (2007)

Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking
por: Li, Li, et al.
Publicado: (2013)

Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent
por: Deng, Li-Hua, et al.
Publicado: (2021)

Erratum to “Magnetic Resonance Imaging of Atherosclerosis Using CD81-Targeted Microparticles of Iron Oxide in Mice”
por: Yan, Fei, et al.
Publicado: (2018)

In situ self-assembly of amphiphilic dextran micelles and superparamagnetic iron oxide nanoparticle-loading as magnetic resonance imaging contrast agents
por: Jiang, Linrui, et al.
Publicado: (2022)

Erratum to: The future of hybrid imaging—part 3: PET/MR, small-animal imaging and beyond
por: Beyer, T., et al.
Publicado: (2012)

Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles
por: Douziech-Eyrolles, Laurence, et al.
Publicado: (2007)

Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool
por: Uchiyama, Mayara Klimuk, et al.
Publicado: (2015)

Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer
por: Czarniecki, Marcin, et al.
Publicado: (2018)

Preparation and characterization of peptide modified ultrasmall superparamagnetic iron oxides used as tumor targeting MRI contrast agent
por: Yin, Jie, et al.
Publicado: (2019)

Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging
por: Unterweger, Harald, et al.
Publicado: (2017)

Erratum to: Motion correction in simultaneous PET/MR brain imaging using sparsely sampled MR navigators: a clinically feasible tool
por: Keller, Sune H., et al.
Publicado: (2015)

Erratum: Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers
Publicado: (2018)

Magnetic Iron Oxide Nanoparticles as T(2) MR Imaging Contrast Agent for Detection of Breast Cancer (MCF-7) Cell
por: Moradi Khaniabadi, Pegah, et al.
Publicado: (2017)

Erratum to: Iron metabolism and iron supplementation in cancer patients
por: Ludwig, Heinz, et al.
Publicado: (2015)

Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)
por: Singh, Neenu, et al.
Publicado: (2010)

Cyclodextrin-Appended Superparamagnetic Iron Oxide Nanoparticles as Cholesterol-Mopping Agents
por: Puglisi, Antonino, et al.
Publicado: (2021)

Superparamagnetic Iron Oxide Nanoparticles Modified with Silica Layers as Potential Agents for Lung Cancer Treatment
por: Reczyńska, Katarzyna, et al.
Publicado: (2020)

Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells
por: Kumar, Manoj, et al.
Publicado: (2012)

Erratum to: Iron deficiency and cardiovascular disease
Publicado: (2023)

Novel MR imaging contrast agents for cancer detection
por: Shahbazi-Gahrouei, Daryoush
Publicado: (2009)

Characterization of Focal Liver Lesions with Superparamagnetic Iron Oxide-Enhanced MR Imaging: Value of Distributional Phase T1-Weighted Imaging
por: Lee, Jeong Min, et al.
Publicado: (2003)

Erratum: Toro, C. et al. On the Detection of Spectral Emissions of Iron Oxides in Combustion Experiments of Pyrite Concentrates. Sensors 2020, 20, 1284
por: Toro, Carlos, et al.
Publicado: (2020)

Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide
por: Alam, Shirjel R., et al.
Publicado: (2015)

Histologic Distribution and Characteristics on MR Imaging of Ultrasmall Superparamagnetic Iron Oxide in Ethyl-nitrosourea-induced Endogenous Rat Glioma
por: Yamamoto, Atsuko, et al.
Publicado: (2020)

Detection of Small Hypervascular Hepatocellular Carcinomas in Cirrhotic Patients: Comparison of Superparamagnetic Iron Oxide-Enhanced MR Imaging with Dual-Phase Spiral CT
por: Lee, Jeong-Min, et al.
Publicado: (2003)

T(1)–T(2) Dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes
por: Szpak, Agnieszka, et al.
Publicado: (2014)

Erratum: 극상건과 극하건 부분 파열의 재고찰: MR 소견을 바탕으로
por: Song, Sinhye, et al.
Publicado: (2022)

Laser speckle contrast imaging identifies ischemic areas on gastric tube reconstructions following esophagectomy: Erratum
Publicado: (2016)

High-sensitivity in vivo contrast for ultra-low field magnetic resonance imaging using superparamagnetic iron oxide nanoparticles
por: Waddington, David E. J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j5hsjkhaudrfmna4jtme7bu0tb